Correlation between Th17 cells and tumor microenvironment

Cellular Immunology

Volumn 285, Issue 1-2, 2013, Pages 18-22

  Qi, Wenhui ^a   Huang, Xiaojuan ^a   Wang, Junyan ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

IL 17; Th17 cells; Tumor microenvironment

Indexed keywords

CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR4; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 17F; INTERLEUKIN 1BETA; INTERLEUKIN 21; INTERLEUKIN 22; INTERLEUKIN 23; INTERLEUKIN 6; STAT3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ANGIOGENESIS; CELL DIFFERENTIATION; CELL FUNCTION; CELL MIGRATION; CORRELATIONAL STUDY; HUMAN; IMMUNE RESPONSE; INTRACELLULAR SIGNALING; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REVIEW; TH17 CELL; TUMOR MICROENVIRONMENT;

IL-17; TH17 CELLS; TUMOR MICROENVIRONMENT;

CARCINOGENESIS; CELL DIFFERENTIATION; CELL MOVEMENT; CYTOKINES; HUMANS; NUCLEAR RECEPTOR SUBFAMILY 1, GROUP F, MEMBER 3; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TH17 CELLS; TUMOR MICROENVIRONMENT;

EID: 84884192749     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2013.06.001     Document Type: Review

References (49)

1. Middleton G.W., Annels N.E., Pandha H.S. Are we ready to start studies of Th17 cell manipulation as a therapy for cancer?. Cancer Immunology Immunotherapy 2012, 1-7.
2. Park H., Li Z., Yang X.O., Chang S.H., Nurieva R., Wang Y.H., Wang Y., Hood L., Zhu Z., Tian Q. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nature Immunology 2005, 6:1133-1141.
3. Bettelli E., Korn T., Oukka M., Kuchroo V.K. Induction and effector functions of TH17 cells. Nature 2008, 453:1051-1057.
4. + T cells and the control of autoimmune disease. Current Opinion in Immunology 2004, 16:695-701.
5. Korn T., Bettelli E., Oukka M., Kuchroo V.K. IL-17 and Th17 cells. Annual Review of Immunology 2009, 27:485-517.
6. Chung Y., Chang S.H., Martinez G.J., Yang X.O., Nurieva R., Kang H.S., Ma L., Watowich S.S., Jetten A.M., Tian Q. Critical regulation of early Th17 cell differentiation by interleukin-1 signaling. Immunity 2009, 30:576-587.
7. + T cells in malignant pleural effusion. The Journal of Immunology 2010, 185:6348-6354.
8. Ghoreschi K., Laurence A., Yang X.P., Tato C.M., McGeachy M.J., Konkel J.E., Ramos H.L., Wei L., Davidson T.S., Bouladoux N. Generation of pathogenic TH17 cells in the absence of TGF-[bgr] signalling. Nature 2010, 467:967-971.
9. McKenzie B.S., Kastelein R.A., Cua D.J. Understanding the IL-23-IL-17 immune pathway. Trends in Immunology 2006, 27:17-23.
10. + IL-17-producing T cells in ovarian cancer. Proceedings of the National Academy of Sciences 2008, 105:15505-15510.
11. Tuomela S., Salo V., Tripathi S.K., Chen Z., Laurila K., Gupta B., Äijö T., Oikari L., Stockinger B., Lähdesmäki H. Identification of early gene expression changes during human Th17 cell differentiation. Blood 2012, 119:e151-e160.
12. Ye J., Livergood R.S., Peng G. The role and regulation of human Th17 cells in tumor immunity. The American Journal of Pathology 2012.
13. Ersvær E., Melve G.K., Bruserud Ø. Future perspectives: should Th17 cells be considered as a possible therapeutic target in acute myeloid leukemia patients receiving allogeneic stem cell transplantation?. Cancer Immunology Immunotherapy 2011, 1-13.
14. Yang X.O., Panopoulos A.D., Nurieva R., Chang S.H., Wang D., Watowich S.S., Dong C. STAT3 regulates cytokine-mediated generation of inflammatory helper T cells. Science Signalling 2007, 282:9358.
15. +/T helper cells. Cell 2006, 126:1121-1133.
16. Stumhofer J.S., Laurence A., Wilson E.H., Huang E., Tato C.M., Johnson L.M., Villarino A.V., Huang Q., Yoshimura A., Sehy D. Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system. Nature Immunology 2006, 7:937-945.
17. Chen Z., Laurence A., Kanno Y., Pacher-Zavisin M., Zhu B.M., Tato C., Yoshimura A., Hennighausen L., O'Shea J.J. Selective regulatory function of Socs3 in the formation of IL-17-secreting T cells. Proceedings of the National Academy of Sciences 2006, 103:8137-8142.
18. Chen Z., Laurence A., O'Shea J.J. Signal transduction pathways and transcriptional regulation in the control of Th17 differentiation. Seminars in Immunology 2007, 400. NIH Public Access.
19. Shi L.Z., Wang R., Huang G., Vogel P., Neale G., Green D.R., Chi H. HIF1α-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells. The Journal of Experimental Medicine 2011, 208:1367-1376.
20. Kryczek I., Wei S., Zou L., Altuwaijri S., Szeliga W., Kolls J., Chang A., Zou W. Cutting edge: Th17 and regulatory T cell dynamics and the regulation by IL-2 in the tumor microenvironment. The Journal of Immunology 2007, 178:6730-6733.
21. Kuang D.M., Peng C., Zhao Q., Wu Y., Chen M.S., Zheng L. Activated monocytes in peritumoral stroma of hepatocellular carcinoma promote expansion of memory T helper 17 cells. Hepatology 2009, 51:154-164.
22. + Th17 cells produce IL-17 in tumor microenvironment and promote tumor progression in human gastric cancer. Oncology Reports 2011, 25:1271.
23. Liu J., Duan Y., Cheng X., Chen X., Xie W., Long H., Lin Z., Zhu B. IL-17 is associated with poor prognosis and promotes angiogenesis via stimulating VEGF production of cancer cells in colorectal carcinoma. Biochemical and Biophysical Research Communications 2011, 407:348-354.
24. Kryczek I., Banerjee M., Cheng P., Vatan L., Szeliga W., Wei S., Huang E., Finlayson E., Simeone D., Welling T.H. Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments. Blood 2009, 114:1141-1149.
25. Munn D.H. Th17 cells in ovarian cancer. Blood 2009, 114:1134-1135.
26. Kesselring R., Thiel A., Pries R., Trenkle T., Wollenberg B. Human Th17 cells can be induced through head and neck cancer and have a functional impact on HNSCC development. British Journal of Cancer 2010, 103:1245-1254.
27. Yang L.J., Qi Y.X., Hu J., Tang L., Zhao S., Shan B.E. Expression of Th17 Cells in breast cancer tissue and its association with clinical parameters. Cell Biochemistry and Biophysics 2012, 1-7.
28. Attig S., Hennenlotter J., Pawelec G., Klein G., Koch S.D., Pircher H., Feyerabend S., Wernet D., Stenzl A., Rammensee H.G. Simultaneous infiltration of polyfunctional effector and suppressor T cells into renal cell carcinomas. Cancer Research 2009, 69:8412-8419.
29. Wainwright D.A., Sengupta S., Han Y., Ulasov I.V., Lesniak M.S. The presence of IL-17A and T helper 17 cells in experimental mouse brain tumors and human glioma. PloS One 2010, 5:e15390.
30. Cantini G., Pisati F., Mastropietro A., Frattini V., Iwakura Y., Finocchiaro G., Pellegatta S. A critical role for regulatory T cells in driving cytokine profiles of Th17 cells and their modulation of glioma microenvironment. Cancer Immunology Immunotherapy 2011, 60:1739-1750.
31. Su X., Ye J., Hsueh E.C., Zhang Y., Hoft D.F., Peng G. Tumor microenvironments direct the recruitment and expansion of human Th17 cells. The Journal of Immunology 2010, 184:1630-1641.
32. Maggi L., Santarlasci V., Capone M., Peired A., Frosali F., Crome S.Q., Querci V., Fambrini M., Liotta F., Levings M.K. CD161 is a marker of all human IL-17-producing T-cell subsets and is induced by RORC. European Journal of Immunology 2010, 40:2174-2181.
33. + regulatory T cells. The Journal of Immunology 2008, 180:122-129.
34. Hirota K., Yoshitomi H., Hashimoto M., Maeda S., Teradaira S., Sugimoto N., Yamaguchi T., Nomura T., Ito H., Nakamura T. Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model. The Journal of Experimental Medicine 2007, 204:2803-2812.
35. Zou W., Restifo N.P. TH17 cells in tumour immunity and immunotherapy. Nature Reviews Immunology 2010, 10:248-256.
36. Wilson N.J., Boniface K., Chan J.R., McKenzie B.S., Blumenschein W.M., Mattson J.D., Basham B., Smith K., Chen T., Morel F. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nature Immunology 2007, 8:950-957.
37. Hirata T., Osuga Y., Takamura M., Kodama A., Hirota Y., Koga K., Yoshino O., Harada M., Takemura Y., Yano T. Recruitment of CCR6-expressing Th17 cells by CCL 20 secreted from IL-1β-, TNF-α-, and IL-17A-stimulated endometriotic stromal cells. Endocrinology 2010, 151:5468-5476.
38. Akimzhanov A.M., Yang X.O., Dong C. Chromatin remodeling of interleukin-17 (IL-17)-IL-17F cytokine gene locus during inflammatory helper T cell differentiation. Journal of Biological Chemistry 2007, 282:5969-5972.
39. Zhang J.P., Yan J., Xu J., Pang X.H., Chen M.S., Li L., Wu C., Li S.P., Zheng L. Increased intratumoral IL-17-producing cells correlate with poor survival in hepatocellular carcinoma patients. Journal of Hepatology 2009, 50:980-989.
40. Numasaki M., Fukushi J., Ono M., Narula S.K., Zavodny P.J., Kudo T., Robbins P.D., Tahara H., Lotze M.T. Interleukin-17 promotes angiogenesis and tumor growth. Blood 2003, 101:2620-2627.
41. Numasaki M., Watanabe M., Suzuki T., Takahashi H., Nakamura A., McAllister F., Hishinuma T., Goto J., Lotze M.T., Kolls J.K. IL-17 enhances the net angiogenic activity and in vivo growth of human non-small cell lung cancer in SCID mice through promoting CXCR-2-dependent angiogenesis. The Journal of Immunology 2005, 175:6177-6189.
42. Tartour E., Fossiez F., Joyeux I., Galinha A., Gey A., Claret E., Sastre-Garau X., Couturier J., Mosseri V., Vives V. Interleukin 17, a T-cell-derived cytokine, promotes tumorigenicity of human cervical tumors in nude mice. Cancer Research 1999, 59:3698-3704.
43. Wang L., Yi T., Kortylewski M., Pardoll D.M., Zeng D., Yu H. IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway. The Journal of Experimental Medicine 2009, 206:1457-1464.
44. Tong Z., Yang X.O., Yan H., Liu W., Niu X., Shi Y., Fang W., Xiong B., Wan Y., Dong C. A protective role by interleukin-17F in colon tumorigenesis. PloS One 2012, 7:e34959.
45. Bronte V. Th17 and cancer: friends or foes?. Blood 2008, 112. 214-214.
46. Kryczek I., Wei S., Szeliga W., Vatan L., Zou W. Endogenous IL-17 contributes to reduced tumor growth and metastasis. Blood 2009, 114:357-359.
47. Sfanos K.S., Bruno T.C., Maris C.H., Xu L., Thoburn C.J., DeMarzo A.M., Meeker A.K., Isaacs W.B., Drake C.G. Phenotypic analysis of prostate-infiltrating lymphocytes reveals TH17 and Treg skewing. Clinical Cancer Research 2008, 14:3254-3261.
48. Prabhala R.H., Pelluru D., Fulciniti M., Prabhala H.K., Nanjappa P., Song W., Pai C., Amin S., Tai Y.T., Richardson P.G. Elevated IL-17 produced by TH17 cells promotes myeloma cell growth and inhibits immune function in multiple myeloma. Blood 2010, 115:5385-5392.
49. + regulatory T cells in the microenvironments of chronic inflammation and cancer. The Journal of Immunology 2011, 186:4388-4395.